Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 5 | 156.25 | 28.48 | 100.00 | 82.75 | 1.2085 | 1.2619 |
| SK-BR-3 | Taxol | 0.31623 | uM | 5 | 156.25 | 28.48 | 67.00 | 82.75 | 0.8097 | 0.7436 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 2.00 | 76.50 | 0.0261 | -0.8448 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 2.00 | 76.50 | 0.0261 | -0.8448 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 2.00 | 76.50 | 0.0261 | -0.8448 | |
| SK-BR-3 | Taxol | 0.01 | uM | 5 | 156.25 | 28.48 | 70.00 | 82.75 | 0.8459 | 0.7939 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 2.00 | 76.50 | 0.0261 | -0.8448 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 2.00 | 76.50 | 0.0261 | -0.8448 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 54.00 | 82.75 | 0.6526 | 0.5155 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 38.00 | 82.75 | 0.4592 | 0.2061 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 4.00 | 76.50 | 0.0523 | -0.7477 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 2.00 | 76.50 | 0.0261 | -0.8448 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 2.00 | 76.50 | 0.0261 | -0.8448 | |
| SK-BR-3 | Methotrexate | 0.01 | uM | 5 | 156.25 | 28.48 | 61.00 | 82.75 | 0.7372 | 0.6405 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 5.00 | 76.50 | 0.0654 | -0.7049 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 5.00 | 76.50 | 0.0654 | -0.7049 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 2.00 | 76.50 | 0.0261 | -0.8448 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 2.00 | 76.50 | 0.0261 | -0.8448 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 2.00 | 76.50 | 0.0261 | -0.8448 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 2.00 | 76.50 | 0.0261 | -0.8448 | |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 5 | 156.25 | 28.48 | 123.00 | 95.00 | 1.2947 | 1.3205 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 5 | 156.25 | 28.48 | 87.00 | 95.00 | 0.9158 | 0.9013 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 5 | 156.25 | 28.48 | 139.00 | 95.00 | 1.4632 | 1.4896 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 5 | 156.25 | 28.48 | 122.00 | 95.00 | 1.2842 | 1.3096 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 86.00 | 95.00 | 0.9053 | 0.8887 |